First National Bank of Omaha Decreases Stock Holdings in Humana Inc. (NYSE:HUM)

First National Bank of Omaha cut its holdings in Humana Inc. (NYSE:HUM) by 12.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,867 shares of the insurance provider’s stock after selling 538 shares during the quarter. First National Bank of Omaha’s holdings in Humana were worth $1,225,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. CarsonAllaria Wealth Management Ltd. increased its holdings in shares of Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares during the last quarter. Creative Financial Designs Inc. ADV increased its stake in Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares during the last quarter. Atwood & Palmer Inc. purchased a new stake in Humana during the third quarter valued at approximately $29,000. Hantz Financial Services Inc. bought a new stake in shares of Humana in the 2nd quarter valued at approximately $35,000. Finally, Family Firm Inc. purchased a new position in shares of Humana in the 2nd quarter worth approximately $37,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of HUM stock opened at $281.73 on Monday. The firm has a market capitalization of $33.92 billion, a price-to-earnings ratio of 24.95, a PEG ratio of 2.18 and a beta of 0.53. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The stock’s 50-day simple moving average is $272.68 and its 200-day simple moving average is $326.83. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $488.89.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, equities analysts forecast that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.26%. The ex-dividend date is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 21st. Oppenheimer cut their price target on shares of Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a report on Thursday, October 3rd. Royal Bank of Canada reduced their price objective on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and upped their target price for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Finally, TD Cowen increased their price target on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $315.86.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.